|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Access Pharmaceuticals Inc., of Dallas, said a Phase III study of OraDisc A for established canker sores achieved its primary endpoint, a measure of accelerated healing by the product on the fifth day. Though Access said the finding was statistically significant, a full statistical analysis of the 700-patient, placebo-controlled, multicenter study has not been completed. The company's stock (AMEX:AKC) gained 11 cents Tuesday to close at $2.41.
o Advanced Tobacco Products Inc., of San Antonio, agreed to merge with IVAX Corp., of Miami. ATP's nicotine impermeable co-polymer technology is used in the Nicotrol/Nicorette inhaler, marketed for smoking cessation by ...